Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Smith & Nephew SNATS, Inc. (SNN : NYSE)

• Company Description    Smith & Nephew is a global medical device company. The company markets clinically superior products, principally in orthopaedics, endoscopy and wound management to deliver cost-effective solutions, significant physicianadvantage and real patient benefits. A continuous process of supplying new and innovative products is supported by substantial R&D investment todeliver new levels of healing to patients throughout the world Number of Employees: 18,000

• Price / Volume Information    Yesterday's Closing Price: $31.98 Daily Weekly Monthly 20 Day Moving Average: 810,150 shares Shares Outstanding: 435.95 (millions) Market Capitalization: $13,941.74 (millions) Beta: 0.62 52 Week High: $44.47 52 Week Low: $29.40 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.13% 6.84% 12 Week -6.65% 2.61% Year To Date -7.63% 11.35%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL BUILDING 5 CROXLEY PARK HATTERS LANE - WATFORD,X0 WD18 8YE GBR ph: 44-19-2347-7100 fax: 44-20-7930-3353 investorrelations.global@smith-nephew.com http://www.smith-nephew.com

• General Corporate Information    Officers Roland Diggelmann - Chief Executive Officer Roberto Quarta - Chairman Anne-Francoise Nesmes - Chief Financial Officer Vinita Bali - Director Ian Barlow - Director Peer Information Smith & Nephew SNATS, Inc. (BJCT) Smith & Nephew SNATS, Inc. (CADMQ) Smith & Nephew SNATS, Inc. (APNO) Smith & Nephew SNATS, Inc. (UPDC) Smith & Nephew SNATS, Inc. (IMTIQ) Smith & Nephew SNATS, Inc. (CYGN) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED PRODUCTS Sector: Medical CUSIP: 83175M205 SIC: 3842 Fiscal Year Fiscal Year End: December Last Reported Quarter: - Next Expected EPS Date: - Share - Related Items Shares Outstanding: 435.95 Most Recent Split Date: 10.00 (2.50:1) Beta: 0.62 Market Capitalization: $13,941.74 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 2.83% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.90 Current Fiscal Year EPS Consensus Estimate: $1.73 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: 8.29% Last Dividend Paid: 03/31/2022 - $0.45 Next EPS Report Date: -

• Fundamental Ratios P/E Current FY Estimate: 18.49 Trailing 12 Months: - PEG Ratio: 2.23 Price Ratios Price/Book: 2.53 Price/Cash Flow: 11.02 Price / Sales: - EPS Growth vs. Year Ago Period: -% vs. Previous Quarter: -% Sales Growth vs. Year Ago Period: -% vs. Previous Quarter: -% ROE 03/31/22 - - 12/31/21 - - 09/30/21 - - ROA 03/31/22 - - 12/31/21 - - 09/30/21 - - Current Ratio 03/31/22 - - 12/31/21 - 2.08 09/30/21 - - Quick Ratio 03/31/22 - - 12/31/21 - 1.21 09/30/21 - - Operating Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Net Margin 03/31/22 - - 12/31/21 - - 09/30/21 - - Pre-Tax Margin 03/31/22 - - 12/31/21 - 11.24 09/30/21 - - Book Value 03/31/22 - - 12/31/21 - 12.66 09/30/21 - - Inventory Turnover 03/31/22 - - 12/31/21 - 0.86 09/30/21 - - Debt-to-Equity 03/31/22 - - 12/31/21 - 0.51 09/30/21 - - Debt-to-Capital 03/31/22 - - 12/31/21 - 33.84 09/30/21 - -

Powered by Zacks Investment Research ©